血清胰岛素样生长因子1与帕金森病伴骨质疏松的相关性研究
作者:
作者单位:

1.新乡医学院,河南 新乡 453003;2.郑州大学附属郑州市中心医院神经内科,河南 郑州 450000

作者简介:

周曼曼,女,硕士研究生。

通信作者:

杨改清,女,主任医师,硕士研究生导师。Email:zxyyygq@163.com。

基金项目:

河南省科技研发专项资金(192102310082);河南省医学科技攻关计划(联合共建)项目(LHGJ20191042)。


Association between serum insulin-like growth factor 1 and Parkinson’s disease with osteoporosis
Author:
Affiliation:

1.Xinxiang Medical College, Xinxiang, Henan 453003, China;2.Department of Neurology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450000, China

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | | | |
    摘要:

    目的 探讨血清胰岛素样生长因子1(IGF-1)与帕金森病(PD)伴骨质疏松(OP)的相关性。方法 回顾性分析105例PD患者(PD组)和78例健康体检人群(HC组)的临床资料。比较2组一般临床资料及血清IGF-1水平的差异。根据双能X线吸收检测法(DXA)进行的骨密度检测结果将PD患者分为PD伴OP组(50例)与PD不伴OP组(55例)。比较2组一般临床资料及血清IGF-1水平的差异。采用皮尔逊相关系数分析血清IGF-1水平与腰椎骨密度及左侧股骨颈骨密度的相关性。采用多因素Logistic回归分析探讨PD伴OP的危险因素。结果 与HC组比较,PD组血清IGF-1水平显著降低(P<0.05)。皮尔逊相关系数分析结果显示,血清IGF-1水平与腰椎骨密度及左侧股骨颈骨密度呈正相关分别(r=0.653,P<0.001;r=0.625,P<0.001 )。多因素Logistic回归分析显示,血清IGF-1、尿酸水平减低及H-Y分期增加是PD伴OP的危险因素(P<0.05)。结论 血清IGF-1、尿酸水平减低及H-Y分期增加与PD伴骨质疏松密切相关。提高血清IGF-1及UA水平可能成为PD伴骨质疏松潜在治疗方法。国际神经病学神经外科学杂志, 2023, 50(6): 7-12]

    Abstract:

    Objective To investigate the association between serum insulin-like growth factor-1 (IGF-1) and Parkinson's disease (PD) with osteoporosis (OP).Methods A retrospective analysis was performed for the clinical data of 105 patients with PD (PD group) and 78 healthy controls (HC group), and general clinical data and serum IGF-1 level were compared between the two groups. Dual-energy X-ray absorptiometry was used to measure bone mineral density (BMD), and then the patients with PD were divided into PD+OP group with 50 patients and non-OP PD group with 55 patients; general clinical data and serum IGF-1 level were compared between the two groups. The Pearson correlation analysis was used to investigate the correlation of serum IGF-1 level with lumbar vertebral BMD and left femoral neck BMD, and the multivariate logistic regression analysis was used to investigate the risk factors for PD in patients with OP.Results Compared with the HC group, the PD group had a significant reduction in serum IGF-1 level (P<0.05). The Pearson correlation analysis showed that serum IGF-1 level was positively correlated with lumbar vertebral BMD (r=0.653, P<0.001) and left femoral neck BMD (r=0.625, P<0.001). The multivariate logistic regression analysis showed that the reductions in serum IGF-1 and uric acid (UA) and the increase in H-Y staging were risk factors for PD in patients with OP (P<0.05).Conclusions The reductions in serum IGF-1 and UA and the increase in H-Y staging are closely associated with PD in patients with OP, and increasing the serum levels of IGF-1 and UA may be a potential therapeutic method for this disorder. [Journal of International Neurology and Neurosurgery, 2023, 50(6): 7-12]

    网友评论
    网友评论
    分享到微博
    发 布
    表 2 PD伴OP组和PD不伴OP组的临床资料比较Table 2
    表 3 PD伴OP发生的多因素分析Table 3
    表 1 PD组和HC组患者临床资料比较Table 1
    图1 PD患者血清IGF-1水平与腰椎骨密度的相关性Fig.1
    图2 PD患者血清IGF-1水平与左侧股骨颈骨密度的相关性Fig.2
    参考文献
    [1] 苏楠,郭雅聪,胡耀凯,等.帕金森病患者血清CysC、Hcy水平及其对伴发脑白质病变的评估作用[J].国际神经病学神经外科学杂志, 2021, 48(6): 511-515.
    [2] 王文斌,于爱红.抑郁症患者骨质疏松发病机制研究进展[J].中华健康管理学杂志, 2022, 16(12): 867-870.
    [3] INOUE T, MAEDA K, NAGANO A, et al. Related factors and clinical outcomes of osteosarcopenia: a narrative review[J]. Nutrients, 2021, 13(2): 291.
    [4] MA C, YU RH, LI JH, et al. Cross-sectional study and bioinformatics analysis to reveal the correlations of osteoporosis in patients with Parkinson's disease[J]. Exp Gerontol, 2023, 173: 112111.
    [5] 李正,肖贵元,何春燕,等.孤独症谱系障碍儿童的血清胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3水平研究[J].中国当代儿科杂志, 2022, 24(2): 186-191.
    [6] 余蓉蓉,张小燕.矮小症患儿血清维生素D、相关元素及其与患儿体格、生长激素、胰岛素样生长因子-1的相关性[J].中国现代医学杂志, 2022, 32(9): 78-83.
    [7] 中国健康促进基金会基层医疗机构骨质疏松症诊断与治疗专家共识委员会.基层医疗机构骨质疏松症诊断和治疗专家共识(2021)[J].中国骨质疏松杂志, 2021, 27(7): 937-944.
    [8] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志, 2016, 49(4): 268-271.
    [9] METTA V, SANCHEZ TC, PADMAKUMAR C. Osteoporosis: a hidden nonmotor face of Parkinson's disease[J]. Int Rev Neurobiol, 2017, 134: 877-890.
    [10] PARK SB, CHUNG CK, LEE JY, et al. Risk factors for vertebral, hip, and femoral fractures among patients with Parkinson's disease: a 5-year follow-up in Korea[J]. J Am Med Dir Assoc, 2019, 20(5): 617-623.
    [11] TAN YJ, LIM SY, YONG VW, et al. Osteoporosis in Parkinson's disease: relevance of distal radius dual-energy X-ray absorptiometry (DXA) and sarcopenia[J]. J Clin Densitom, 2021, 24(3): 351-361.
    [12] WANG B, LIN X, ZHOU JH, et al. Insulin-like growth factor-1 improves postoperative cognitive dysfunction following splenectomy in aged rats[J]. Exp Ther Med, 2021, 21(3): 215.
    [13] BELETSKIY A, CHESNOKOVA E, BAL N. Insulin-like growth factor 2 as a possible neuroprotective agent and memory enhancer-its comparative expression, processing and signaling in mammalian CNS[J]. Int J Mol Sci, 2021, 22(4): 1849.
    [14] CASTILLA-CORTáZAR I, AGUIRRE G A, FEMAT-ROLDáN G, et al. Is insulin-like growth factor-1 involved in Parkinson's disease development?[J]. J Transl Med, 2020, 18(1): 70.
    [15] BIANCHI VE, LOCATELLI V, RIZZI L. Neurotrophic and neuroregenerative effects of GH/IGF1[J]. Int J Mol Sci, 2017, 18(11): 2441.
    [16] ASHPOLE NM, HERRON JC, MITSCHELEN MC, et al. IGF-1 regulates vertebral bone aging through sex-specific and time-dependent mechanisms[J]. J Bone Miner Res, 2016, 31(2): 443-454.
    [17] 孙晓燕,汤海燕.不同亚型帕金森病患者血清尿酸、载脂蛋白A1及谷胱甘肽水平对比[J].中国老年学杂志, 2022, 42(12): 2963-2965.
    [18] SEIFAR F, DINASARAPU AR, JINNAH HA. Uric acid in Parkinson's disease: what is the connection?[J]. Mov Disord, 2022, 37(11): 2173-2183.
    [19] D?N?U A, DUMITRESCU L, LEFTER A, et al. Serum uric acid levels in Parkinson's disease: a cross-sectional electronic medical record database study from a tertiary referral centre in Romania[J]. Medicina (Kaunas), 2022, 58(2): 245.
    [20] SONG JD, LIU T, ZHAO JX, et al. Causal associations of hand grip strength with bone mineral density and fracture risk: a mendelian randomization study[J]. Front Endocrinol (Lausanne), 2022, 13: 1020750.
    [21] 马速,顾平,仇福成,等.帕金森病患者骨质疏松的临床观察[J].中国骨质疏松杂志, 2021, 27(6): 838-842.
    引证文献
引用本文

周曼曼,徐志强,高雯雯,等.血清胰岛素样生长因子1与帕金森病伴骨质疏松的相关性研究[J].国际神经病学神经外科学杂志,2023,50(6):7-12.ZHOU M,XU Z,GAO W,et al. Association between serum insulin-like growth factor 1 and Parkinson’s disease with osteoporosis[J]. Journal of International Neurology and Neurosurgery,2023,50(6):7-12

复制
分享
文章指标
  • 点击次数:145
  • 下载次数: 720
历史
  • 收稿日期:2023-06-12
  • 最后修改日期:2023-10-24
  • 在线发布日期: 2024-06-20
关闭
关闭